Dachaigh › Aillse Prostata › Pennsylvania › Philadelphia
Sgrùdaidhean clionaigeach Aillse Prostata ann an Philadelphia, PA
Tha 44 sgrùdaidhean airson Aillse Prostata a’ lorg phàirtichean aig làraichean ann agus timcheall air Philadelphia (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A’ fastadhÌre 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
A’ fastadhÌre 3
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mìle air falbh
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mìle air falbh
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
A’ fastadhÌre 1
- Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia
DESTINY-PANTUMOUR04
A’ fastadhSgrùdadh amharc
- Research Site, Philadelphia
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
A’ fastadhÌre 3
- Fox Chase Cancer Center ( Site 0076), Philadelphia
- MidLantic urology ( Site 0022), Bala-Cynwyd · 5 mìle air falbh
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A’ fastadhÌre 3
- MidLantic urology, Bala-Cynwyd · 5 mìle air falbh
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
A’ fastadhÌre 2/3
- Fox Chase Cancer Center, Philadelphia
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
A’ fastadhÌre 2
- Philadelphia MultiService Center, Philadelphia, PA, Philadelphia
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
A’ fastadhÌre 3
- Perelman Center for Advanced Medicine ( Site 0067), Philadelphia
- Abramson Cancer Center - Penn Medicine ( Site 0079), Philadelphia
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
A’ fastadhÌre 1/2
- GSK Investigational Site, Philadelphia
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
A’ fastadhÌre 1
- Thomas Jefferson University, Philadelphia
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
A’ fastadh
- MidLantic Urology, Bala-Cynwyd · 5 mìle air falbh
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
A’ fastadhÌre 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mìle air falbh
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mìle air falbh
A Study of Tarlatamab for People With Prostate Cancer
A’ fastadhÌre 2
- Thomas Jefferson University Hospital, Philadelphia
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
A’ fastadhÌre 1
- Thomas Jefferson University, Philadelphia
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
A’ fastadhÌre 2
- Abramson Cancer Center of the University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
A’ fastadhÌre 3
- Penn Presbyterian Medical Center, Philadelphia
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
A’ fastadhÌre 1
- Thomas Jefferson University Honickman Center, Philadelphia
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
A’ fastadhÌre 1
- Thomas Jefferson University, Philadelphia
PSMA PET Combined With MRI for the Detection of PCa
A’ fastadhÌre 3Fàilte do shaor-thoilich fhallain
- MidLantic Urology, Philadelphia
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1
- Investigative Site #109, Philadelphia
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
A’ fastadhÌre 3
- Philadelphia Veterans Administration Medical Center, Philadelphia
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mìle air falbh
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mìle air falbh
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
A’ fastadhÌre 1
- MidLantic Urology, Bala-Cynwyd · 5 mìle air falbh
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
A’ fastadhÌre 1
- Thomas Jefferson University, Philadelphia
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
A’ fastadhÌre 1/2
- Thomas Jefferson University Hospital, Philadelphia
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
A’ fastadhÌre 2
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia
TERPS Trial for de Novo Oligometastic Prostate Cancer
A’ fastadhÌre 2
- Sidney Kimmel Cancer Center at Jefferson Health, Philadelphia
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
A’ fastadhSgrùdadh amharc
- Fox Chase Cancer Center - Temple Health, Philadelphia
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
A’ fastadh
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
A’ fastadhÌre 2/3
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
A’ fastadhÌre 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Study of AZD0754 in Participants With Metastatic Prostate Cancer
A’ fastadhÌre 1/2
- Research Site, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
A’ fastadhÌre 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Hypofractionated WPPT With HDR Boost
A’ fastadhÌre 2
- University of Pennsylvania, Philadelphia
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
A’ fastadhÌre 1
- MidLantic Urology, Bala-Cynwyd · 5 mìle air falbh
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
A’ fastadhÌre 4
- Albert Einstein Healthcare Network, Philadelphia
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
A’ fastadhÌre 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mìle air falbh
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mìle air falbh
Prostate Tissue BioBank
A’ fastadhSgrùdadh amharc
- University of Pennsylvania, Philadelphia
Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer
A’ fastadh
- Fox Chase Cancer Center, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Philadelphia
Sgrùdaidhean Aillse Prostata ann am bailtean eile
- New York City, NY103 sgrùdaidhean
- Houston, TX76 sgrùdaidhean
- Los Angeles, CA61 sgrùdaidhean
- Boston, MA59 sgrùdaidhean
- St. Louis, MO46 sgrùdaidhean
- Chicago, IL45 sgrùdaidhean
- San Francisco, CA45 sgrùdaidhean
- Baltimore, MD43 sgrùdaidhean
- Nashville, TN43 sgrùdaidhean
- Seattle, WA42 sgrùdaidhean
- Washington, DC38 sgrùdaidhean
- Dallas, TX36 sgrùdaidhean
Sgrùdaidhean eile ann an Philadelphia
- Aillse (gach seòrsa)59 sgrùdaidhean
- Aillse a' bhroilleach56 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag51 sgrùdaidhean
- Ailse metastatach46 sgrùdaidhean
- Aillse colorectal44 sgrùdaidhean
- Cancer Ovarian44 sgrùdaidhean
- Ailseachadh nan Sgamhan36 sgrùdaidhean
- Leukemia myeloid geur34 sgrùdaidhean
- Fàilligeadh a' Chridhe31 sgrùdaidhean
- Ailse Endometrial28 sgrùdaidhean
- Depression26 sgrùdaidhean
- Cancer Pancreatic26 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.